Siemens Healthineers, The Ohio State University Wexner Medical Center Form 10-year, $105 million Value Partnership
Press release

Siemens Healthineers, The Ohio State University Wexner Medical Center Form 10-year, $105 million Value Partnership

Joint Press Release by Siemens Healthineers and The Ohio State University Wexner Medical Center
Published on November 25, 2024
  • Through their investment in imaging technology for diagnosis and treatment of cancer and cardiac and neurological conditions, Siemens Healthineers will support The Ohio State Wexner Medical Center to enhance healthcare delivery 
  • Dedicated scientists from The Ohio State University and Siemens Healthineers to bolster the long-standing collaboration on translational research to advance clinical practice 
  • As part of this Value Partnership, Siemens Healthineers will support The Ohio State University’s creation of a center of imaging excellence

Siemens Healthineers and The Ohio State Wexner Medical Center have expanded their existing strategic relationship to form a 10-year, $105 million Value Partnership1 to foster breakthroughs in clinical care, in addition to their longstanding research collaboration. The two parties are partnering to accelerate innovation in diagnostic and therapeutic imaging, AI and machine learning in radiology and radiation oncology and access to high-quality care for underserved patients. The new Value Partnership will include equipment purchases and consulting services over 10 years to transform care delivery through operational improvements and workforce development programs. 

A team of scientists from Siemens Healthineers will join the clinical and research teams from across The Ohio State Wexner Medical Center, the Ohio State Heart and Vascular Center and Richard M. Ross Heart Hospital, and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) to collaborate on translational research to advance clinical practice at a new center for imaging excellence. The imaging center will bring together scientists, physicians, engineers, clinicians and learners from multiple disciplines to develop practical innovations that can be rapidly translated to practice for treating various types of diseases at The Ohio State Wexner Medical Center and health systems around the world. 

“Combining the strengths of both our institutions allows us to achieve more for the benefit of our patients, locally and globally,” said John J. Warner, MD, CEO of The Ohio State University Wexner Medical Center and executive vice president at Ohio State. “We have a deep bench of subspecialized scientists working in cancer, heart, neuroscience and other disciplines. Along with Siemens Healthineers, we can solve medical challenges and adapt therapies in real time for the betterment of our patients – and that is a very meaningful opportunity that we’re excited to take on together.” 

For more than 15 years, Siemens Healthineers and Varian, a Siemens Healthineers company, have been primary providers to The Ohio State Wexner Medical Center and OSUCCC – James for most of their imaging equipment, including MRI, CT, molecular imaging, X-ray, interventional radiology and radiation oncology. 

“Our relationship with The Ohio State Wexner Medical Center brings out the best in both organizations,” said David Pacitti, president and head of the Americas at Siemens Healthineers. “Not only are we providing them with advanced imaging and other modalities, but through our research collaboration, we’re also co-developing technologies that can save and improve patients’ lives.” 

Innovations that have come out of the longstanding The Ohio State Wexner Medical Center - Siemens Healthineers collaboration in heart and vascular imaging include MRI techniques to detect inflammation of the heart muscle, rapid techniques for imaging cardiac function and blood flow, and methods to image the heart using a lower-cost, lower-field strength MRI scanner.

Download image
1

Siemens Healthineers 2025

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at www.siemens-healthineers.com.